用CRISPR/Cas9编辑哈普罗型作为NEFL中主导-负误解突变的治疗方法
Poorvi H Dua1,2, Bazilco M J Simon2, Chiara B E Marley1,2
1Department of Pediatrics, University of California, San Francisco, San Francisco, CA, USA.
bioRxiv : the preprint server for biology
|January 7, 2025
概括
哈普洛型编辑使主导NEFL突变无效,用于治疗神经退行性疾病. 这种方法针对特定的遗传变异,为患有主导遗传疾病的患者提供广泛的治疗策略.
科学领域:
- 遗传学 遗传学 是一个
- 分子生物学分子生物学
- 神经科学是一个神经科学.
背景情况:
- 主导阴性遗传疾病,例如由NEFL突变引起的,带来治疗挑战.
- 对等位基因特定的基因编辑通过使致病等位基因失活提供了一个潜在的治疗策略.
- 之前的研究表明,在患者衍生细胞中成功编辑了单个NEFL误解突变.
研究的目的:
- 为多个NEFL误解突变开发一种多功能基因编辑策略.
- 为了研究对NEFL相关疾病的哈普洛型编辑的疗效和特异性.
- 为治疗应用探索和优化基因编辑结果.
主要方法:
- 在cis中准单核酸多态 (SNPs) 具有NEFL突变的基因切除.
- 利用诱导多能干细胞 (iPSC) 衍生的运动神经元来模拟疾病和测试编辑效率.
- 开发新的分子测试来评估编辑结果和异位基因特异性干扰.
- 采用种群遗传学来评估哈普洛型编辑策略的治疗范围.
主要成果:
- 哈普洛型编辑成功地针对iPSC运动神经元中的两个不同的NEFL误解突变.
- 发现切除编辑的副产品基因逆转,对于破坏突变性等位基因表达是不可靠的.
- 为提高治疗编辑效率和特异性,开发了替代策略和新型分析.
- 种群遗传学分析证实了对不同患者种群的哈普洛型编辑的广泛适用性.
结论:
- 哈普洛型编辑是治疗广泛的主导NEFL突变的有希望的策略.
- 优化基因编辑方法对于最大化治疗结果和特异性至关重要.
- 这项研究为开发其他主要遗传疾病的基于哈普洛型的疗法提供了有价值的框架.
更多相关视频
07:46CRISPR/Cas9 Editing of the C. elegans rbm-3.2 Gene using the dpy-10 Co-CRISPR Screening Marker and Assembled Ribonucleoprotein Complexes.
Published on: December 11, 2020
5.8K
09:04Generation of Defined Genomic Modifications Using CRISPR-CAS9 in Human Pluripotent Stem Cells
Published on: September 25, 2019
8.2K
相关概念视频
01:59CRISPR
49.3K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
49.3K
02:53Conservative Site-specific Recombination and Phase Variation
5.9K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
5.9K